DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Curtis JR, Herrem C, Ndlovu N. et al.
A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial.
Arthritis Res Ther 2017;
19: 215
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.